Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada

Community-based educational intervention to limit the dissemination of community-associated methicillin-resistant Staphylococcus aureusin Northern Saskatchewan, Canada

(2012) George R Golding et al.   BMC PUBLIC HEALTH

Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistantStaphylococcus aureus(CA-MRSA)

(2012) Lance R. Thurlow et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

National Surveillance of Methicillin-resistant Staphylococcus aureus Among Hospitalized Pediatric Patients in Canadian Acute Care Facilities, 1995–2007

(2012) Anne Matlow et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007–2009 study

(2011) George G. Zhanel et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Comparison of community-associated and health care-associated methicillin-resistant Staphylococcus aureus in Canada: results of the CANWARD 2007–2009 study

(2011) Kimberly A. Nichol et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus (MRSA) among Patients Admitted to Adult Intensive Care Units: The STAR*ICU Trial

(2011) Nisha Nair et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Increasing Role of Staphylococcus aureus and Community-Acquired Methicillin-Resistant Staphylococcus aureus Infections in the United States: A 10-Year Trend of Replacement and Expansion

(2011) Robertino M. Mera et al.   Microbial Drug Resistance

Emergence of Resistance among USA300 Methicillin-Resistant Staphylococcus aureus Isolates Causing Invasive Disease in the United States

(2010) L. K. McDougal et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic

(2010) M. Z. David et al.   CLINICAL MICROBIOLOGY REVIEWS

Methicillin-Resistant Staphylococcus aureus Colonization or Infection in Canada: National Surveillance and Changing Epidemiology, 1995–2007

(2010) Andrew E. Simor et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006

(2009) H. J. Adam et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Community-Associated Meticillin-Resistant Staphylococcus aureus Infections

(2009) Mukesh Patel   DRUGS

Characterization of Methicillin-Resistant Staphylococcus aureus Isolates Collected in 2005 and 2006 from Patients with Invasive Disease: a Population-Based Analysis

(2009) B. Limbago et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Are Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Strains Replacing Traditional Nosocomial MRSA Strains?

(2008) K. J. Popovich et al.   CLINICAL INFECTIOUS DISEASES

Coexistence of Panton‐Valentine Leukocidin–Positive and –Negative Community‐Associated Methicillin‐ResistantStaphylococcus aureusUSA400 Sibling Strains in a Large Canadian Health‐Care Region

(2008) Kunyan Zhang et al.   JOURNAL OF INFECTIOUS DISEASES